Falsified and Substandard Drugs: Stopping the Pandemic
Gaurvika M. L. Nayyar(Rady Children's Hospital-San Diego), James E. Herrington(University of North Carolina at Chapel Hill), Jocalyn Clark(International Centre for Diarrhoeal Disease Research), Mustapha Hajjou(United States Pharmacopeial Convention), Tim K. Mackey(University of California San Diego), Megan Littrell(Program for Appropriate Technology in Health), Joel G. Breman
Cited by 117
Related Papers
A review of existing and emerging digital technologies to combat the global trade in fake medicines
|Expert Opinion on Drug Safety|2017|356
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries
|JAMA Network Open|2018|333
‘Fit-for-purpose?’ – challenges and opportunities for applications of blockchain technology in the future of healthcare
|BMC Medicine|2019|323
Review of Florida red tide and human health effects
|Harmful Algae|2010|249